Markus I. Anzaldua-Campos
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Single-cell and spatial transcriptomics
- T-cell and B-cell Immunology
- Mathematical Biology Tumor Growth
- Galectins and Cancer Biology
- Nanoplatforms for cancer theranostics
- Glioma Diagnosis and Treatment
- Photoacoustic and Ultrasonic Imaging
- Photodynamic Therapy Research Studies
Harvard University
2023-2024
Harvard University Press
2023-2024
Massachusetts General Hospital
2023-2024
Recent clinical trials have highlighted the limited efficacy of T cell-based immunotherapy in patients with glioblastoma (GBM). To better understand characteristics tumor-infiltrating lymphocytes (TIL) GBM, we performed cellular indexing transcriptomes and epitopes by sequencing single-cell RNA paired V(D)J sequencing, respectively, on TILs from two cohorts totaling 15 high-grade glioma, including GBM or astrocytoma, IDH-mutant, grade 4 (G4A). Analysis CD8+ TIL landscape reveals an...
<p>Gene markers for Xenium in situ cell type identification.</p>
<p>Heatmap of top differentially expressed genes by CD8+ T cell states from cohorts 1 and 2.</p>
<p>scGSEA correlation values</p>
<p>Dot plot of select gene markers for cell type identification CD8+ T cells from cohort 1.</p>
<p>Comparison of CD8+ GZMK+ TIL from IDH-WT GBM and IDH-mut G4A samples.</p>
<p>Antibody markers and respective clone numbers.</p>
<p>Patient demographics and sample characteristics.</p>
<p>Comparison of TIL from primary and recurrent GBM samples.</p>
<p>Harmony integration of TIL from many cancer types.</p>
<p>Inhibitory score analysis of the integrated T cells from cohorts 1 and 2.</p>
<p>Gene markers for cell type identification and gene signatures.</p>
<p>MAIT clonotype occurrence in T cells from cohort 1.</p>
<p>Analysis of RNA Tirosh exhaustion and inhibitory scores expressed by T cells from cohort 1.</p>
<p>Neighborhood enrichment raw z scores</p>
<p>DEGs of various T cell populations</p>
<p>Analysis of GBM tumor Xenium spatial sample.</p>
<p>TCR landscape of ex vivo expanded TIL does not recapitulate the initial TCR landscape.</p>
<p>DEGs of various T cell populations</p>
<p>Comparison of CD8+ GZMK+ TIL from IDH-WT GBM and IDH-mut G4A samples.</p>
<p>Antibody markers and respective clone numbers.</p>
<p>Dot plot of select gene markers for cell type identification CD8+ T cells from cohort 1.</p>
<p>Gene markers for Xenium in situ cell type identification.</p>
<p>Supplementary Fig. S10 genes and associated GO BPs</p>
<p>Harmony integration of TIL from many cancer types.</p>